Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Raymond James downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The firm likes the company’s active portfolio ...

Teleflex Incorporated (NYSE:TFX) will pursue a plan to separate into two new, independent, publicly traded companies: New, ...

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex shares tumbled to a 52-week low on Thursday after the medical-technology company posted disappointing financial guidance and unveiled plans for a nearly $800 million acquisition and a spinoff ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex faced multiple downgrades from investment banks on Friday after the company reported disappointing fourth-quarter ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Medical equipment maker Teleflex said on Thursday it would split into two companies, retaining three of its segments along with its recently acquired $800 million business, while separating its slower ...